Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.


the science and practice of diagnosis of disease.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.


(di?ag-nos'tiks) [ diagnos(is) + -ics]
The science, art, or practice of diagnosis.

companion diagnostics

Laboratory tests and test kits used to determine the suitability of patients for tailored or targeted forms of therapy, e.g., therapies that act on unique biochemical pathways or that require specific genotypes or mutations.

molecular diagnostics

Molecular pathology (2).
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
Blue Earth Diagnostics is a leading molecular imaging diagnostics company focussed on the development and commercialisation of novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need.
The most common cancer diagnostic methods are biopsy, sentinel node biopsy, endoscopy, blood tests, bone marrow aspiration, Pap test, sputum and bronchial washing analysis, imaging studies, genetic analysis, etc.
In addition to the biological and logistic limitations of traditional companion diagnostics, the economic implications for using single biomarker assays are becoming more significant as reimbursement for high-complexity laboratory tests continues to decrease.
Changes in the diagnostic plot can indicate shifts in the liquid to gas flow rate ratio, and the diagnostics are also good at monitoring the health of each DP transmitter.
Molecular Diagnostics focuses on developing predictive tools that can assist in patient prognosis and treatment.
This chapter also focuses on opportunities for public sector partnerships to defray costs, ease evaluation and assist market entry for improved diagnostics.
For many providers of research products for nucleic acid analysis technologies other than PCR, the molecular diagnostics market represents a new market opportunity, for which their technology platforms can be utilized by providers of molecular diagnostics assays to create new clinical diagnostic tests.
It has not been cleared or approved by authorities including the United States Food and Drug Administration or any other regulatory agency in the United States, or under the European IVD Directive, for human diagnostic or other clinical use, and is not intended and should not be used for human diagnostic or any other clinical purposes.
Customers and competitors identified a large number of alternative immunochemistry test firms in a position to replace Siemens and Bayer Diagnostics in case of price increases.
IVAX Diagnostics, Inc.(AMEX:IVD), Miami, Fla., has reported its financial results for the first quarter of 2005.

Full browser ?